Stock Market Close Report, August 11, 2026: Sensex, Nifty Decline as Oil, Financials Weigh on Benchmarks

Mumbai, August 11: Indian benchmark indices ended lower on Tuesday, extending their cautious run as elevated crude oil prices and fading hopes of a quick U.S.-Iran peace agreement weighed on risk appetite. Selling was concentrated in realty, metal, FMCG and financial stocks, while gains in pharmaceutical and IT shares offered some support. The Nifty 50 closed below the 24,500 mark. 

At close, the Sensex fell 388.19 points, or 0.49%, to 78,154.25, while the Nifty 50 declined 112.10 points, or 0.46%, to 24,471.70. Market breadth remained negative, with 1,977 shares advancing, 2,152 declining and 187 remaining unchanged. 

The weakness came despite renewed foreign buying and a relatively resilient broader market. Foreign investors have bought Indian equities worth $1.5 billion on a net basis so far in August, following inflows of $2.1 billion in July. However, they remain net sellers for the year, having offloaded a record $25.7 billion from Indian shares so far in 2026. 

Realty, Metal, Financial Stocks Lead Decline 

Sectoral performance remained weak, with the Nifty Realty, FMCG and Metal indices each falling around 1%. Nifty Infrastructure declined 0.8%, while Nifty Private Bank slipped 0.6%. Nifty Auto and Nifty Bank ended 0.5% and 0.4% lower, respectively. 

Financial stocks were among the biggest drags on the market, with weakness in banks adding to pressure from realty and metal counters, reflecting the broader risk-off mood. 

The selling pressure in rate-sensitive and economically sensitive sectors came even as investors continued to selectively buy stocks backed by strong earnings. 

Pharma, IT Stocks Outperform 

Pharmaceutical stocks emerged as the strongest-performing pocket of the market, with the Nifty Pharma index gaining 1%. Nifty IT also advanced 0.6%, extending its recent run of outperformance, helped by easing expectations of further U.S. Federal Reserve rate hikes. 

Dr Reddy’s Laboratories emerged as the top Nifty gainer, while Eternal, TCS, Titan Company and Infosys also ended higher. 

The strength in IT and pharma helped cushion the broader market decline as investors looked for earnings-led opportunities amid uncertainty over oil. 

Gland Pharma Surges 

Gland Pharma was among the biggest stock-specific movers after the drugmaker reported better-than-expected first-quarter earnings. The stock jumped 9.6% during the session after brokers upgraded the stock to ‘Buy’ from ‘Hold’. 

The sharp move in Gland Pharma added to the strength in the pharmaceutical sector, highlighting the continued focus on companies delivering earnings surprises despite the broader risk-off environment. 

Stocks In Focus 

Among the major Nifty losers, Tata Consumer Products, Max Healthcare, UltraTech Cement, Apollo Hospitals and Nestle India came under selling pressure. Weakness in FMCG and healthcare counters added to the cautious tone across the market. 

The contrast between earnings-driven gains in select stocks and broader selling pressure underscored the increasingly stock-specific nature of the market, with investors rewarding companies that delivered strong quarterly numbers while remaining cautious on sectors vulnerable to higher input and financing costs. 

Crude Oil, U.S.-Iran Tensions Weigh 

Crude oil remained the biggest macro overhang for Indian equities. Oil prices climbed to a one-week high on Tuesday as hopes of a U.S.-Iran peace agreement faded after the two sides traded demands over compensation. 

The rise in crude prices is particularly significant for India, one of the world’s largest oil importers. Sustained higher energy costs could widen the country’s import bill, fuel inflation, put pressure on the rupee and squeeze corporate profit margins. 

The oil rally has kept Indian benchmark indices subdued over the past four trading sessions, although stronger-than-expected corporate earnings and renewed foreign inflows have helped prevent a sharper deterioration in sentiment. 

Midcaps, Smallcaps Show Resilience 

Despite the decline in the headline indices, the broader market remained relatively resilient. The Nifty Midcap index ended unchanged, while the Nifty Smallcap index gained 0.2%. 

The resilience in broader markets suggests that investors continue to hunt for stock-specific opportunities even as large-cap equities remain vulnerable to global macro risks. Earnings visibility and domestic-focused businesses are likely to remain key drivers of performance as the quarterly results season progresses. 

Foreign Buying Offers Some Support 

A notable positive for Indian equities is the return of foreign buying after months of heavy outflows. Foreign investors’ net purchases of $1.5 billion in August, on top of $2.1 billion in July, mark a significant shift in sentiment. 

Market strategists have attributed the renewed buying to better-than-expected first-quarter earnings. However, the sizeable year-to-date foreign outflow means investors will continue to monitor whether the recent buying trend can be sustained. 

What Next For Indian Markets? 

The near-term direction of Indian equities is likely to remain closely linked to crude oil prices and developments around the U.S.-Iran peace process, particularly any signals on the Strait of Hormuz. Investors will also track foreign fund flows, the rupee and the ongoing corporate earnings season. 

For now, strong earnings and renewed foreign buying are providing a counterweight to the oil shock. However, a sustained rise in crude could intensify concerns over inflation, margins and India’s external balances, keeping the benchmarks under pressure. 

The Sensex and Nifty ended lower for the session, with the Nifty settling at 24,471.70, as weakness in realty, metal, FMCG and financial stocks outweighed gains in pharma and IT counters. 

Source

• NSE
• BSE